Astrazeneca PLC News Headlines

AZN 
$68.9
*  
0.11
0.16%
Get AZN Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is A Dividend Cut The End Of The World? Stock Price Recovery And The Contrarian View, Part IV
2/3/2015 6:42:00 PM - Seeking Alpha


Ardelyx Reports Results From Phase 2b Trial Of Tenapanor In Hyperphosphatemia
2/2/2015 7:28:00 AM - RTT News


Moving On From Pfizer's 2009 Dividend Cut
2/1/2015 12:29:00 AM - Seeking Alpha


Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog
1/28/2015 6:10:00 AM - Investopedia


Pfizer Hit by Stronger Dollar, Patent Losses -- 2nd Update
1/27/2015 4:21:00 PM - Dow Jones Business News


Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog
1/27/2015 10:51:00 AM - Investopedia


Pfizer Hit by Stronger Dollar, Patent Losses -- Update
1/27/2015 7:41:00 AM - Dow Jones Business News


Pfizer Hit by Stronger Dollar, Patent Losses
1/27/2015 7:32:00 AM - Dow Jones Business News


Teva Obtains FDA Approval For First Generic Nexium Delayed-Release Capsules
1/26/2015 3:41:00 PM - RTT News


AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog
1/26/2015 10:50:00 AM - Investopedia


A New Price Estimate Now That Afrezza Is Launching
1/26/2015 8:58:00 AM - Seeking Alpha


Is A Dividend Cut The End Of The World? The Impact On Dividend Income, Part III
1/26/2015 7:11:00 AM - Seeking Alpha


Will Pfizer (PFE) Beat Q4 Earnings Despite Generics? - Analyst Blog
1/23/2015 11:30:00 AM - Investopedia


Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog
1/23/2015 4:20:00 AM - Investopedia


My Top 10 Dividend Growth Stock Portfolio Continues To Generate Income Growth: UPDATED
1/22/2015 1:24:00 PM - Seeking Alpha


How To Profit From These 3 Overvalued Sectors
1/22/2015 8:30:00 AM - Investopedia


News Flash: The Endocrine Society Recommends Weight Loss Medications
1/21/2015 11:15:00 AM - Seeking Alpha


Actavis/Gedeon Richter Present Schizophrenia Drug Data - Analyst Blog
1/20/2015 4:30:00 AM - Investopedia


Qiagen Up on CE-IVD Mark for New Liquid Biopsy Test Kit - Analyst Blog
1/15/2015 2:10:00 PM - Investopedia


Agilent Arm/Cell Signaling Tie for Companion Diagnostics - Analyst Blog
1/15/2015 12:30:00 PM - Investopedia


AstraZeneca Announces Encouraging Data from Brilinta Study - Analyst Blog
1/15/2015 10:30:00 AM - Investopedia


Update: AstraZeneca Inks Lucrative Deal With Omnis Pharmaceuticals
1/15/2015 2:46:00 AM - Seeking Alpha


Update: AstraZeneca Anti-Clotting Drug Moves Closer To Market
1/14/2015 2:56:00 PM - Seeking Alpha


AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog
1/14/2015 4:10:00 AM - Investopedia


AstraZeneca: PEGASUS-TIMI 54 Trial Meets Primary Efficacy Endpoint - Quick Facts
1/14/2015 2:57:00 AM - RTT News